Summary
The effects of some muscarinic M1 and M2 receptor agonists and antagonists on two dopamine-mediated behavioural paradigms, namely postswim grooming response and apormorphine-induced climbing behaviour, was investigated in mice. The M1 agonists and M2 receptor antagonists attenuated both paradigms, whereas the M1 receptor antagonists and M2 receptor agonists facilitated both behaviours. However, carbachol and physostigmine, exhibited a similar dose-dependent dual effect with the lower doses augmenting and the higher doses inhibiting both the behaviours, suggesting that the M2 agonist receptor specificity is lost on dose increment. The findings indicate that the central cholinergic muscarinic heteroreceptors, like the other muscarinic receptors, are functionally divisible into M1 and M2 receptor subtypes in their modulation of dopaminergic activity.
This is a preview of subscription content, log in via an institution to check access.
References
Bhattacharya SK, Sen AP (1991) Effects of some selective muscarinic M1 & M2 receptor agonists and antagonists on rat brain dopaminergic activity. Biogen Amines (in press)
Chesher GB, Jackson DM (1980) Post-swim grooming in mice inhibited by dopamine receptor antagonists and by cannabinoids. Pharmacol Biochem Behav 13: 479–481
Costall BR, Fortune DH, Naylor RJ, Nohria V (1980) The mesolimbic system, denervation and the climbing response in the mouse. Eur J Pharmacol 66: 207–215
Finkelstein Y, Sternfeld M, Flechter S, Kushnir A, Hod I (1990) Septal dopaminergiccholinergic interactions during stress. Stress Med 6: 3–7
Fung YK, Novin-Baheran A, Bosch TK, Grassman DR (1982) An in vivo method for testing GABAergic compounds. Pharmacol Biochem Behav 17: 651–654
Goyal RK (1989) Muscarinic receptor subtypes: physiology and clinical implications. N Engl J Med 321: 1022–1029
Hoss W, Ellis J (1985) Muscarinic receptor subtypes in the central nervous system. Int Rev Neurobiol 26: 151–199
Iversen SD (1977) Brain dopamine systems and behaviour. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology, vol 8. Plenum Press, New York, pp 333–384
Kilbinger H (1985) Facilitation and inhibition by muscarinic agonists of acetylcholine release from guineapig myenteric neurones: mediation through different types of neuronal muscarinic receptors. Trends Pharmacol Sci 5 [Suppl]: 49–52
Liskowsky DR, Potter DR (1985) Muscarinic binding sites localized to cortical dopamine neurones. Neurosci Lett 58: 229–234
Marchi M, Raiteri M (1985) On the presence in the central cortex of muscarinic receptor subtypes which differ in neuronal localization, function and pharmacological properties. J Pharmacol Exp Ther 235: 230–233
Mukhopadhyay M, Upadhyay SN, Bhattacharya SK (1987) Neuropharmacological studies on selective monoamine oxidase A and B inhibitors. Indian J Exp Biol 25: 761–770
Raiteri M, Leardi R, Marchi M (1984) Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain. J Pharmacol Exp Ther 228: 209–214
Schoffelmeer G, Mulder AH (1986) Muscarinic receptor-mediated modulation of (3H) dopamine and (14C) acetylcholine release from rat neonatal slices: selective antagonism by gallamine but not pirenzepine. Eur J Pharmacol 128: 291–294
Sen AP (1988) The cholinergic system in certain drug-induced experimental paradigms. Thesis, Banaras Hindu University
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bhattacharya, S.K., Sen, A.P. Effects of muscarinic receptor agonists and antagonists on dopamine-mediated behavioural paradigms. J. Neural Transmission 84, 241–246 (1991). https://doi.org/10.1007/BF01244975
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01244975